Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Completed 4

Sponsor Class

INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 4Head & Neck 1

Conditions

Melanoma 4Skin Neoplasms 3Neoplasms 3Neoplasm Metastasis 2

Interventions

pembrolizumab 181Nivolumab 117Ipilimumab 97Dacarbazine 48trametinib 37dabrafenib 353-ingenyl angelate 35Vemurafenib 33cemiplimab 27atezolizumab 24Temozolomide 24binimetinib 23Paclitaxel 22Imiquimod 22encorafenib 17avelumab 17Carboplatin 17Aminolevulinic Acid 17spartalizumab 16cobimetinib 16Cyclophosphamide 15Cisplatin 15Fluorouracil 14talimogene laherparepvec 13HhAntag691 11Gels 11Drug Therapy 11Bevacizumab 11lenvatinib 10durvalumab 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Allovectin-7 × Dermatologic × Clear all
NCT00395070 2013-09-13

A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma

Vical

Phase 3 Completed
390 enrolled
Dermatologic

Melanoma, Neoplasm Metastasis

NCT00003646 2011-07-07

Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma

Vical

Phase 2 Completed
78 enrolled
Dermatologic

Melanoma, Neoplasms, Skin Neoplasms

NCT00044356 2011-07-07

Phase II Trial of Allovectin-7® for Metastatic Melanoma

Vical

Phase 2 Completed
133 enrolled
Dermatologic

Melanoma, Neoplasm Metastasis, Neoplasms, Skin Neoplasms

NCT00003647 2008-07-25

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

Vical

Phase 3 Completed
Dermatologic

Melanoma, Neoplasms, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡